Health Canada - Federal department responsible for drug approvals and health regulation in Canada
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| PMS-METHYLPHENIDATE CR | Pharmascience Inc | Marketed | Oct 30, 2023 | Marketed |
| PRO-ZOLPIDEM ODT | PRO DOC LIMITEE | Marketed | Oct 30, 2023 | Marketed |
| PMS-METHYLPHENIDATE CR | Pharmascience Inc | Marketed | Oct 30, 2023 | Marketed |
| PMS-METHYLPHENIDATE CR | Pharmascience Inc | Marketed | Oct 30, 2023 | Marketed |
| BACITRACIN OINTMENT | safetec of america inc | Marketed | Oct 30, 2023 | Marketed |
| PMS-METHYLPHENIDATE CR | Pharmascience Inc | Marketed | Oct 30, 2023 | Marketed |
| PMS-METHYLPHENIDATE CR | Pharmascience Inc | Marketed | Oct 30, 2023 | Marketed |
| AURO-LURASIDONE | auro pharma inc | Marketed | Oct 30, 2023 | Marketed |
| AURO-LURASIDONE | auro pharma inc | Marketed | Oct 30, 2023 | Marketed |
| AURO-LURASIDONE | auro pharma inc | Marketed | Oct 30, 2023 | Marketed |
| PMS-METHYLPHENIDATE CR | Pharmascience Inc | Marketed | Oct 30, 2023 | Marketed |
| PRO-ZOLPIDEM ODT | PRO DOC LIMITEE | Marketed | Oct 30, 2023 | Marketed |
| PMS-METHYLPHENIDATE CR | Pharmascience Inc | Marketed | Oct 30, 2023 | Marketed |
| PACLITAXEL POWDER FOR INJECTABLE SUSPENSION NANOPARTICLE, ALBUMIN-BOUND PACLITAXEL | PANACEA BIOTEC PHARMA LIMITED | Marketed | Oct 27, 2023 | Marketed |
| TRIKAFTA | Vertex Pharmaceuticals (Canada) Incorporated | Marketed | Oct 27, 2023 | Marketed |
| TRIKAFTA | Vertex Pharmaceuticals (Canada) Incorporated | Marketed | Oct 27, 2023 | Marketed |
| HADLIMA | Samsung Bioepis Co., Ltd. | Marketed | Oct 25, 2023 | Marketed |
| HADLIMA PUSHTOUCH | Samsung Bioepis Co., Ltd. | Marketed | Oct 25, 2023 | Marketed |
| FLECAINIDE | sanis health inc | Marketed | Oct 24, 2023 | Marketed |
| FLUCONAZOLE | sivem pharmaceuticals ulc | Marketed | Oct 24, 2023 | Marketed |
